Could these twins' rare genetic disorder provide the key to preventing cancer?

Key Points:

• The town of Piñas in southern Ecuador has a high prevalence of Laron syndrome, a rare genetic disorder causing short stature due to growth hormone insensitivity, affecting about 840 people worldwide.
• Research led by endocrinologist Dr. Jaime Guevara and others has found that individuals with Laron syndrome have significantly lower rates of cancer and diabetes, likely due to their inability to produce Insulin-like Growth Factor 1 (IGF-1), which may promote cancer cell survival.
• Studies comparing Laron patients and their normal-height relatives over 22 years revealed almost no cases of diabetes and very few cancer cases among Laron patients, suggesting the growth hormone receptor mutation offers protective effects.
• Despite these protective factors, Laron syndrome patients are not completely immune to diseases, as evidenced by one twin's colon cancer diagnosis, highlighting the need for continued caution and care.
• A drug called Increlex can increase height if administered during childhood growth periods, but it is costly, limited in availability, and not accessible to all patients, leaving many adults with Laron syndrome to accept their stature while hoping for future therapeutic advances.